SOPH Stock Summary and Trading Ideas (Sophia Genetics SA - | NASDAQ:SOPH)

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

Sophia Genetics SA - trades on the NASDAQ stock market under the symbol SOPH.

As of February 6, 2026, SOPH stock price climbed to $4.80 with 22,272 million shares trading.

SOPH has a beta of 1.55, meaning it tends to be more sensitive to market movements. SOPH has a correlation of 0.21 to the broad based SPY ETF.

SOPH has a market cap of $318.91 million. This is considered a Small Cap stock.

Last quarter Sophia Genetics SA - reported $19 million in Revenue and -$.30 earnings per share. This beat revenue expectation by $1 million and missed earnings estimates by -$.10.

In the last 3 years, SOPH traded as high as $7.37 and as low as $2.13.

The top ETF exchange traded funds that SOPH belongs to (by Net Assets): ONEQ.

SOPH has outperformed the market in the last year with a return of +26.3%, while the SPY ETF gained +14.6%. In the last 3 month period, SOPH beat the market returning +6.2%, while SPY returned +1.4%. However, in the most recent 2 weeks SOPH has underperformed the stock market by returning -13.0%, while SPY returned -0.6%.

SOPH support price is $4.39 and resistance is $4.81 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SOPH shares will trade within this expected range on the day.